Projects

Evaluation of the in-vitro susceptibility for Cefepime-Enmetazobactam in Cephalosporin resistant isolates of Enterobacterales from urine samples

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - Ongoing

Project Lead

Ms. Manasa S

Authors

Ms. Manasa S, Dr. Priyadarshini A Padaki, Dr. Sneha May Kurian

Project Status

ongoing

Project Type

Diagnostic/Validational study